Neurocrine Biosciences' GAAP net income for the three months of 2021 was $32.1 million, down 14.2% from $37.4 million in the previous year. Revenue decreased 0.2% to $236.6 million from $237.1 million a year earlier.
Neurocrine Biosciences' GAAP net income for the three months of 2021 was $32.1 million, down 14.2% from $37.4 million in the previous year. Revenue decreased 0.2% to $236.6 million from $237.1 million a year earlier. 
neurocrine.gcs-web.com
English (US) 